Imidazo/2,1-b/benzothiazoles useful in the treatment of memory disorders and/or irritable conditions
CA 1331991 C · Owner: Kay, David Paul · Inventors: Kay, David Paul; Hedgecock, Charles John Robert
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Disclosed are new imidazo2,1-bbenzothiazoles of formula I, (I), wherein R1 represents a group of formula II (II), in which R4 and R5 are H or alkyl and R6 is H alkyl, phenyl, halogen, alkoxycarbonyl cyano, amido or a mono- or, dialkylamido or R1 represents a group of formula III (III), in which R7 and R8 are H or alkyl; and R2 and R3 together represent a group, or , in which m is 1 to 3 and X1 and X2 are H alkyl, alkenyl, alkoxy, arylalkoxy, aryloxy halogen, nitrile or azido; or, X1 and X2 together represent methylenedioxy and acid, addition salts thereof. Processes for preparing these new compounds which possess benzodiazepine inverse agonist and/or tranquilising properties are also …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted September 13, 1994. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended September 13, 2011.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.